AI assistant
Ajanta Pharma Ltd. — Board/Management Information 2020
Jul 20, 2020
59171_rns_2020-07-20_297c557d-fe6e-48ac-903c-9ae13e88a99a.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Ajanta House T +91 22 6606 1000 Charkop, Kandivli West, F +91 22 6606 1200 Mumbai 400 067 E [email protected] India W www.ajantapharma.com
==> picture [292 x 28] intentionally omitted <==
20[th] July 2020
| BSE LIMITED | National Stock Exchange of India, |
|---|---|
| Phiroze Jeejeebhoy Towers | Exchange Plaza, 5thFloor, Plot no. |
| Dalal Street, | C/1, G Block, Bandra Kurla Complex, |
| Mumbai – 400001 | Bandra (East), Mumbai – 400 051 |
| Scrip Code: BSE – AJANTPHARM 532331 | Scrip Code: NSE AJANTPHARM EQ |
Re: Notice of Board meeting
Dear Sir/Madam,
Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Thursday, 30[th] July 2020, to inter-alia, consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30[th] June 2020.
Kindly take the above information on record.
Thanking you. Yours faithfully,
Gauran Digitally signed by Gaurang Shah Date: 2020.07.20 10:56:19 +05'30' g Shah Gaurang Shah AVP – Legal & Company Secretary
Corporate Identity Number – L24230MH1979PLC022059